StreetInsider.com News Articles

Form 4 Maze Therapeutics, Inc. For: May 29 Filed by: Dandekar Atul

Tue, 02 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260602/26591772.html

Form 4 Maze Therapeutics, Inc. For: May 29 Filed by: Dandekar Atul

Tue, 02 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260602/26591772.html

Form 144 Maze Therapeutics, Inc. Filed by: Coloma Jason V

Mon, 01 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260601/26583904.html

Form 144 Maze Therapeutics, Inc. Filed by: Coloma Jason V

Mon, 01 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260601/26583904.html

Form 4 Maze Therapeutics, Inc. For: May 22 Filed by: Coloma Jason V

Wed, 27 May 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260527/26558108.html

Form 4 Maze Therapeutics, Inc. For: May 22 Filed by: Coloma Jason V

Wed, 27 May 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260527/26558108.html

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Wed, 27 May 2026 07:03:00 -0400

SOUTH SAN FRANCISCO, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced that Jason Coloma, Ph.D., chief executive officer of Maze Therapeutics, will participate in two upcoming investor conferences:

2026 Jefferies Global Healthcare Conference in New York; presentation on Wednesday, June 3, 2026, at 3:45 p.m. ET
Goldman Sachs 47th Annual Global Healthcare Conference 2026; presentation on Wednesday, June 10, 2026, at 8:40 a.m. ET

Live webcasts of the events will be available in

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Wed, 27 May 2026 07:03:00 -0400

2026 Jefferies Global Healthcare Conference in New York; presentation on Wednesday, June 3, 2026, at 3:45 p.m. ET
Goldman Sachs 47th Annual Global Healthcare Conference 2026; presentation on Wednesday, June 10, 2026, at 8:40 a.m. ET

Live webcasts of the events will be available in

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Wed, 27 May 2026 07:03:00 -0400

2026 Jefferies Global Healthcare Conference in New York; presentation on Wednesday, June 3, 2026, at 3:45 p.m. ET
Goldman Sachs 47th Annual Global Healthcare Conference 2026; presentation on Wednesday, June 10, 2026, at 8:40 a.m. ET

Live webcasts of the events will be available in

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Wed, 27 May 2026 07:03:00 -0400

2026 Jefferies Global Healthcare Conference in New York; presentation on Wednesday, June 3, 2026, at 3:45 p.m. ET
Goldman Sachs 47th Annual Global Healthcare Conference 2026; presentation on Wednesday, June 10, 2026, at 8:40 a.m. ET

Live webcasts of the events will be available in

Form 8-K Maze Therapeutics, Inc. For: May 18

Fri, 22 May 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260522/26542934.html

Form 8-K Maze Therapeutics, Inc. For: May 18

Fri, 22 May 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260522/26542934.html

Form 4 Maze Therapeutics, Inc. For: May 15 Filed by: Coloma Jason V

Mon, 18 May 2026 17:07:00 -0400

si-local-file:///var/storage/secattach/20260518/26514992.html

Form 4 Maze Therapeutics, Inc. For: May 15 Filed by: Coloma Jason V

Mon, 18 May 2026 17:07:00 -0400

si-local-file:///var/storage/secattach/20260518/26514992.html

Form 4 Maze Therapeutics, Inc. For: May 14 Filed by: Bernstein Harold

Mon, 18 May 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260518/26514921.html

Form 4 Maze Therapeutics, Inc. For: May 14 Filed by: Bernstein Harold

Mon, 18 May 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260518/26514921.html

Form 144 Maze Therapeutics, Inc. Filed by: Coloma Jason V

Fri, 15 May 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260515/26507738.html

Form 144 Maze Therapeutics, Inc. Filed by: Coloma Jason V

Fri, 15 May 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260515/26507738.html

Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC

Fri, 15 May 2026 12:38:00 -0400

si-local-file:///var/storage/secattach/20260515/26502879.html

Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC

Fri, 15 May 2026 12:38:00 -0400

si-local-file:///var/storage/secattach/20260515/26502879.html

Form EFFECT Maze Therapeutics, Inc.

Thu, 14 May 2026 06:09:00 -0400

si-local-file:///var/storage/secattach/20260514/26489236.html

Form EFFECT Maze Therapeutics, Inc.

Thu, 14 May 2026 06:09:00 -0400

si-local-file:///var/storage/secattach/20260514/26489236.html

Maze Therapeutics (MAZE) Tops Q1 EPS by 13c

Tue, 12 May 2026 17:19:37 -0400

Maze Therapeutics (NASDAQ: MAZE) reported Q1 EPS of ($0.45), $0.13 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $20 million.

For earnings history and earnings-related data on Maze Therapeutics (MAZE) click here.

Form 10-Q Maze Therapeutics, Inc. For: Mar 31

Tue, 12 May 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260512/26477940.html

Form 10-Q Maze Therapeutics, Inc. For: Mar 31

Tue, 12 May 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260512/26477940.html